Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET
Company Participants
Jenny Gelinas - VP, IR
Richard Poulton - CEO
Thomas Langan - President and Chief Commercial Officer
Leah Jones - CFO
Conference Call Participants
Stephanie Davis - SVB Securities
Charles Rhyee - Cowen and Company
Thomas Keller - RBC Capital Markets
George Hill - Deutsche Bank
Cynthia Motz - Goldman Sachs
Eric Percher - Nephron Research
Operator
Greetings, and welcome to Allscripts' Third Quarter 2022 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
I would now like to turn the conference over to your host, Jenny Gelinas. Thank you. You may begin.
Jenny Gelinas
Thank you very much. Good afternoon, and welcome to the Allscripts Third Quarter 2022 Earnings Conference Call. Our speakers today are Rick Poulton, Allscripts' Chief Executive Officer; Tom Langan, President and Chief Commercial Officer; and Leah Jones, our Chief Financial Officer.
We will be making a number of forward-looking statements during the presentation and the Q&A part of the call. These statements are based on current expectations and involve a number of risks and uncertainties that could cause our actual results to vary materially. We undertake no obligation to revise these forward-looking statements in light of new information or future events. Please refer to our earnings release and SEC filings for more information regarding the risk factors that may affect our results. Please reference the GAAP and non-GAAP financial statements as well as the non-GAAP tables in our earnings release that are available on our Investor Relations website.
And with that, I'm going to hand the call over to Rick.
Richard Poulton
Okay. Thanks, Jenny, and thanks, everybody, for joining us on our third quarter call today. 5 weeks ago we hosted our Investor Day in New York City. I know many of you were able to join us either in person or virtually and heard directly from key members of our leadership team our strategy for creating value across our 3-sided network of providers, payers and life sciences clients. For those of you who were unable to participate, I do encourage you to view the webcast, which can still be accessed on our Investor Relations website. .
Over the course of that presentation, we laid out our business strategies in great detail, so I'll keep my prepared remarks, particularly brief today and just share a few thoughts on what I think investors and analysts should be focused on as they digest our third quarter results.